Načítá se...
Use of hemodialysis for the treatment of intracerebral hemorrhage in patients on dabigatran with normal renal function
Dabigatran is a direct thrombin inhibitor which is approved by the Food and Drug Administration (FDA) for prevention of embolic stroke in patients with atrial fibrillation. Dabigatran has been shown to be non- inferior to warfarin in preventing stroke in patients with atrial fibrillation [1, 6]. The...
Uloženo v:
| Vydáno v: | Clin Nephrol Case Stud |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dustri-Verlag Dr. Karl Feistle
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437993/ https://ncbi.nlm.nih.gov/pubmed/29043124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS108253 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|